Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a24c06d7efa58043

Jump to content

Talk:Mirabegron

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 7 years ago by MaynardClark in topic Prevalence of prescription and use

Prevalence of prescription and use

[edit]

If 43% of US women have been diagnosed with OAB, what is the current prevalence of prescription and use of Myrbetriq® (mirabegron) among US women? MaynardClark (talk) 00:55, 29 October 2018 (UTC)Reply

  1. Myrbetriq [Prescribing Information]. Northbrook, IL: Astellas Pharma US, Inc.
  2. Astellas. Myrbetriq. Data on File.
  3. Federal Aviation Administration. Federal Air Surgeon’s Medical Bulletin. Oklahoma City, OK: Federal Aviation Administration. 2013‑2014;51(4):6.

MaynardClark (talk) 00:55, 29 October 2018 (UTC)Reply